Yale University
New Haven, Connecticut
Private University
Founded 1701
Yale is a premier research university with strong commercialization in biomedical sciences, pharmaceuticals, and medical devices.
$1.5B
R&D (FY2024)
70
US Patents (2025)
267
Disclosures (FY2025)
83
Licenses (FY2025)
10
Startups (FY2025)
$102.9M
Business-Funded R&D
Research and Commercialization Data
Total R&D Expenditures
5-Year Change: 38.9%
Avg: 1259.4
- Research spending (FY2024): $1.5B total, of which $102.9M was funded by business. NSF National Center for Science and Engineering Statistics
- US patents granted (2025): 70 (rank #30). National Academy of Inventors
- Tech transfer (FY2025): 267 invention disclosures, 83 licenses and options, 10 startups. Yale Ventures
Research Focus Areas
Pharmaceuticals & Drug Discovery
Small molecule and biologic drug development
Yale School of MedicineChemistry
Biomedical Engineering
Medical devices and diagnostics
Biomedical Engineering
Neuroscience
Brain disorders and neural circuits
Kavli Institute for Neuroscience
Related Market Maps
Explore market opportunities in deep tech categories relevant to Yale's research focus.
View all market maps →Notable Spinouts
Achillion Pharmaceuticals
Founded 1998 • Pharmaceuticals
Antiviral drug development company
$926.2M deal valueby Alexion Pharmaceuticals
Programs & Resources
Tech Transfer Office
Yale Ventures
Services Offered
- •Technology licensing
- •Startup support
- •IP management
- •Industry partnerships
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization